Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
Hmg09Kfrpygr2ZW9
